Medical Gas Plasma Promotes Apoptosis Accompanied by Immunomodulation in Gastrointestinal Tumor Cells
Cancers · 03.11.2026 · 18 (21) · 3526
DOI: 10.3390/cancers18213526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 03.11.2026. Verfasst von Lisa-Marie Zietz und 5 weiteren Autor:innen. Beteiligte Einrichtung: ZIK plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Forschung, Technologie und Raumfahrt, German Federal Ministry of Research, Technology, and Space, Excellence Research Scholarship of the state of Mecklenburg-Western Pomerania.
Abstract (Originalsprache)
Background/Objectives: Medical plasma is a promising therapeutic approach in oncology due to its ability to generate reactive oxygen and nitrogen species (RONS) and modulate tumor cell viability and phenotype. Therefore, medical plasma could expand the treatment options for highly prevalent or difficult-to-treat cancer entities such as gastrointestinal cancers.
Methods
This study investigated the effects of medical plasma generated by the clinically certified argon plasma jet kINPen on two gastrointestinal tumor cell lines (HT-29, MUG-CCArly) with a focus on cytotoxicity, immunomodulation, and redox-dependent mechanisms.
Results
Plasma produced a mixture of reactive species under the applied experimental conditions and was able to reduce metabolic activity and cell viability via a redox-dependent induction of apoptosis in both cell lines. Plasma exposure altered the expression of cell-surface markers with potentially immunostimulatory roles such as CD40, CRT, and HMGB1, as well as more immunoregulatory markers like CD47 and PD-L1 (CD274). Additionally, modulated secretion profiles marked by increased pro-inflammatory molecules such as IL-8 and MIP-3a (CCL20) were detected.
Conclusion
Overall, congruent but also cell line-dependent responses to plasma treatment were observed that featured a modified immunological phenotype of tumor cells with potentially immunostimulatory but also immunomodulatory aspects, highlighting the potential of medical gas plasma technology as a multimodal therapeutic approach in gastrointestinal oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ZIK plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany.
- Department of Dermatology, Venerology, and Allergology, Rostock University Medical Center, Strempelstr. 13, 18057 Rostock, Germany.
- Department of Hematology and Oncology, Greifswald University Medical Center, Sauerbruchstr., 17475 Greifswald, Germany.
ORCID-Profile: Debora Singer, Sander Bekeschus
Förderung
- Bundesministerium für Forschung, Technologie und Raumfahrt
- German Federal Ministry of Research, Technology, and Space
- Excellence Research Scholarship of the state of Mecklenburg-Western Pomerania
- Rostock Academy of Sciences
Zitieren
APA
Zietz, L. M., Pritzkow, T., Singer, D., Martinet, A., Miebach, L., & Bekeschus, S. (2026). Medical Gas Plasma Promotes Apoptosis Accompanied by Immunomodulation in Gastrointestinal Tumor Cells. Cancers, 18(21), 3526. https://doi.org/10.3390/cancers18213526
Vancouver
Zietz LM, Pritzkow T, Singer D, Martinet A, Miebach L, Bekeschus S. Medical Gas Plasma Promotes Apoptosis Accompanied by Immunomodulation in Gastrointestinal Tumor Cells. Cancers. 2026;18(21):3526. doi:10.3390/cancers18213526
BibTeX
@article{Zietz2026,
author = {Zietz, Lisa-Marie and Pritzkow, Tino and Singer, Debora and Martinet, Alice and Miebach, Lea and Bekeschus, Sander},
title = {Medical Gas Plasma Promotes Apoptosis Accompanied by Immunomodulation in Gastrointestinal Tumor Cells},
journal = {Cancers},
year = {2026},
volume = {18},
number = {21},
pages = {3526},
doi = {10.3390/cancers18213526}
}
EUVIMED